J.W. Cole Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-26,136
Closed -$23.7M 1177
2025
Q4
$23.7M Buy
26,136
+241
+0.9% +$230K 0.57% 21
2025
Q3
$19.8M Buy
25,895
+786
+3% +$585K 0.38% 42
2025
Q2
$19.6M Buy
25,109
+6,301
+34% +$4.9M 0.42% 35
2025
Q1
$15.5M Buy
18,808
+8,960
+91% +$7.46M 0.48% 31
2024
Q4
$7.6M Buy
9,848
+300
+3% +$248K 0.31% 64
2024
Q3
$8.46M Buy
9,548
+205
+2% +$184K 0.35% 53
2024
Q2
$8.46M Buy
9,343
+157
+2% +$126K 0.4% 43
2024
Q1
$7.14M Buy
9,186
+130
+1% +$92.5K 0.36% 53
2023
Q4
$5.28M Sell
9,056
-410
-4% -$239K 0.31% 75
2023
Q3
$5.08M Sell
9,466
-488
-5% -$251K 0.37% 57
2023
Q2
$4.67M Sell
9,954
-2,283
-19% -$957K 0.33% 69
2023
Q1
$4.2M Buy
12,237
+4,781
+64% +$1.61M 0.3% 77
2022
Q4
$2.73M Sell
7,456
-152
-2% -$53.9K 0.21% 122
2022
Q3
$2.46M Buy
7,608
+842
+12% +$267K 0.21% 122
2022
Q2
$2.19M Buy
6,766
+465
+7% +$140K 0.17% 146
2022
Q1
$1.8M Buy
6,301
+922
+17% +$237K 0.12% 196
2021
Q4
$1.49M Buy
5,379
+282
+6% +$71.5K 0.1% 227
2021
Q3
$1.18M Buy
5,097
+411
+9% +$101K 0.08% 150
2021
Q2
$1.07M Buy
4,686
+364
+8% +$73.1K 0.08% 262
2021
Q1
$807K Buy
4,322
+1,046
+32% +$205K 0.08% 280
2020
Q4
$553K Sell
3,276
-8,626
-72% -$1.29M 0.06% 323
2020
Q3
$1.76M Buy
+11,902
New +$1.84M 0.14% 168
2020
Q1
Sell
-3,128
Closed -$411K 332
2019
Q4
$411K Buy
+3,128
New +$363K 0.05% 344

Other funds holding LLY

J.W. Cole Advisors's LLY Position: Q1 2026 in Review

J.W. Cole Advisors sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 26,136 shares — an estimated $23.7M sold.

J.W. Cole Advisors first reported a position in LLY in Q4 2019 and held it in 23 quarters. The position peaked at $23.7M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • J.W. Cole Advisors reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • J.W. Cole Advisors sold 26,136 Eli Lilly shares in Q1 2026, an estimated $23.7M.
  • J.W. Cole Advisors first reported a position in Eli Lilly in Q4 2019 and held it in 23 quarters.
  • J.W. Cole Advisors's Eli Lilly position peaked at $23.7M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on J.W. Cole Advisors's 13F filing for Q1 2026, filed 23 Apr 2026.